Reventus Pharma Revenue

Biotechnology Research • Lyon, Auvergne-Rhône-Alpes, France • 1-10 Employees

Reventus Pharma revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at Reventus Pharma

Pierre-Axel Monternier

Chief Executive Officer

Company overview

Headquarters	Lyon, Auvergne-Rhône-Alpes, France
NAICS	541714
Founded	2023
Employees	1-10

About Reventus Pharma

Reventus Pharma a pour objectif de développer des thérapies pour les maladies rares métaboliques. Pour cela, notre équipe sera au service des patients sans traitement, pour leur proposer une solution thérapeutique le plus efficacement et le plus rapidement possible. Reventus Pharma aims to develop therapies for rare metabolic diseases. To achieve this, our team will be dedicated to serving patients without treatment, offering them a therapeutic solution as efficiently and swiftly as possible.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Reventus Pharma has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Reventus Pharma has never raised funding before.

Frequently asked questions

Reventus Pharma is located in Lyon, Auvergne-Rhône-Alpes, FR.

Reventus Pharma generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Reventus Pharma has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Reventus Pharma was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Reventus Pharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Reventus Pharma

Pierre-Axel Monternier

Chief Executive Officer

4.8

40,000 users